MIRA Pharmaceuticals (MIRA) has completed its acquisition of SKNY Pharmaceuticals,. As part of the transaction, SKNY fulfilled all closing ...
Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback